Cargando…
Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09
Oral antiviral agents to treat influenza are challenging to administer in the intensive care unit (ICU). We describe 57 critically ill patients treated with the investigational intravenous neuraminidase inhibitor drug peramivir for influenza A (H1N1)pdm09 [pH1N1]. Most received late peramivir treatm...
Autores principales: | Louie, Janice K., Yang, Samuel, Yen, Cynthia, Acosta, Meileen, Schechter, Robert, Uyeki, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386960/ https://www.ncbi.nlm.nih.gov/pubmed/22768265 http://dx.doi.org/10.1371/journal.pone.0040261 |
Ejemplares similares
-
A Review of Adult Mortality Due to 2009 Pandemic (H1N1) Influenza A in California
por: Louie, Janice K., et al.
Publicado: (2011) -
Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015–2016 season in Japan
por: Hibino, Akinobu, et al.
Publicado: (2016) -
Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016) -
Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013) -
Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)